Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis

计划入组 20 人 · 首次发布于 2009 年 6 月 4 日

Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis

计划入组 35 人 · 首次发布于 2011 年 10 月 12 日

Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

计划入组 21 人 · 首次发布于 2010 年 12 月 24 日

Masitinib

C₂₈H₃₀N₆OS

AB-8779

Recombinant human insulin biosimilar(Rechon Life Science AB)

Rechon Life Science AB

Sweden

Genenta Science

Olink Holding AB

Sweden

EMA's CHMP Recommends 10 New Medicines, Including Novel Therapies and Biosimilars

AB Science Provides Update on Masitinib and AB8939 Clinical Programs

AB Science Secures Chinese Patent for Masitinib in COVID-19 Treatment Until 2041